FDA inspection
Altaire Pharmaceuticals, Inc.: FDA inspection ending Feb 11, 2022
FDA inspection 1162640 · Official Action Indicated (OAI) · Aquebogue, NY
Key facts
| Inspection ID | 1162640 |
|---|---|
| Firm | Altaire Pharmaceuticals, Inc. |
| FEI number | 1000119582 |
| Address | 311 W Ln |
| City | Aquebogue |
| State | NY |
| ZIP | 11931 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Feb 11, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| Product type | Veterinary |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data